Brind.

Omnicell stock underperformed S&P 500 gains on September 1, 2025.

1 report, 1 independent Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Omnicell stock underperformed S&P 500 gains on September 1, 2025.

Who's involved

What this event is mainly about
Omnicell

Keep exploring

The entities involved

  • Omnicell

    American healthcare technology company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • StockStoryOmnicell (OMCL): Buy, Sell, or Hold Post Q2 Earnings? Over the past six months, Omnicell’s stock price fell to $32.30. Shareholders have lost 14.4% of their capital, which is disappointing considerin